Risk factors and long-term follow-up in acute Kawasaki disease patients with medium or large coronary artery

Wei Li1, Yuantao Tong2, Xiqiao Xue1

  • 1Department of Cardiology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

Insights

Delayed IVIG treatment and IVIG resistance are risk factors for Kawasaki disease (KD) patients with medium or large coronary artery abnormalities (CAA). Long-term prognosis for medium and large CAA is poor, especially for large CAA.

Area of Science:

  • Pediatrics
  • Cardiology
  • Rheumatology

Background:

  • Kawasaki disease (KD) is a leading cause of acquired heart disease in children.
  • Medium or large coronary artery abnormalities (CAA) in KD patients require further investigation.
  • Limited data exists on risk factors and long-term outcomes for KD patients with medium/large CAA in Chinese populations.

Purpose of the Study:

  • To identify risk factors for developing medium or large CAA in Kawasaki disease.
  • To evaluate the long-term follow-up and prognosis of KD patients with medium or large CAA.
  • To analyze the regression rates and thrombosis development in different CAA categories.

Main Methods:

  • A cohort study of 220 KD patients (55 with medium/large CAA, 165 without CAA) was conducted from January 2015 to April 2020.
  • Univariate and multivariate logistic regression analyses were employed to determine risk factors.
  • Patients were followed up for over 12 months to assess long-term outcomes.

Main Results:

  • Independent risk factors for medium/large CAA included delayed IVIG treatment, IVIG resistance, low albumin, and low platelet count.
  • At 49 months follow-up, 54.3% of medium CAA regressed, but none of the large CAA cases resolved.
  • Coronary thrombosis increased from 20% in acute phase to 32.7% at follow-up, predominantly in the large CAA group.

Conclusions:

  • Delayed IVIG, IVIG resistance, albumin, and platelet count are significant risk factors for medium/large CAA in KD.
  • The long-term prognosis for medium and large CAA is concerning, with large CAA showing a particularly poor outlook.
  • Close monitoring and timely intervention are crucial for KD patients with coronary artery abnormalities.
Abstract

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...